Evidence map›Paper›PMID 25041568›Full record

ArticleChemical biology & drug design2014

Specific interaction between Mycobacterium tuberculosis lipoprotein-derived peptides and target cells inhibits mycobacterial entry in vitro.

Marisol Ocampo, Hernando Curtidor, Magnolia Vanegas, Manuel A Patarroyo, Manuel E Patarroyo

Open access · greenAbstract readEditorial
In one paragraph

Article in Chemical biology & drug design, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Peptide-Based Vaccines for Tuberculosis.Frontiers in immunology · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Marisol OcampoFundación Instituto de Inmunología de Colombia (FIDIC), Carrera 50 No. 26-20, Bogotá, Colombia; Universidad del Rosario, Carrera 24 No. 63C-69, Bogotá, Colombia; Universidad Nacional de Colombia, Carrera 45 No. 26-85, Bogotá, Colombia.
Hernando Curtidor
Magnolia Vanegas
Manuel A Patarroyo
Manuel E Patarroyo
Universidad del Rosario · COFundación Instituto de Inmunología de Colombia · CO

Funding

NIAID NIH HHS N01 AI040091
6 · The paper itself

Abstract

Tuberculosis (TB) continues being one of the diseases having the greatest mortality rates around the world, 8.7 million cases having been reported in 2011. An efficient vaccine against TB having a great impact on public health is an urgent need. Usually, selecting antigens for vaccines has been based on proteins having immunogenic properties for patients suffering TB and having had promising results in mice and non-human primates. Our approach has been based on a functional approach involving the pathogen-host interaction in the search for antigens to be included in designing an efficient, minimal, subunit-based anti-TB vaccine. This means that Mycobacterium tuberculosis has mainly been involved in studies and that lipoproteins represent an important kind of protein on the cell envelope which can also contribute towards this pathogen's virulence. This study has assessed the expression of four lipoproteins from M. tuberculosis H37Rv, that is, Rv1411c (LprG), Rv1911c (LppC), Rv2270 (LppN) and Rv3763 (LpqH), and the possible biological activity of peptides derived from these. Five peptides were found for these proteins which had high specific binding to both alveolar A549 epithelial cells and U937 monocyte-derived macrophages which were able to significantly inhibit mycobacterial entry to these cells in vitro.

Indexed as

Amino Acid SequenceAntibodiesBacterial ProteinsCell Line, TumorComputational BiologyHost-Pathogen InteractionsHumansLipoproteinsMicrospheresMolecular Sequence DataMycobacterium tuberculosisPeptidesProtein BindingProtein Structure, SecondaryU937 CellsAntibodiesBacterial ProteinsLipoproteinsPeptidesantituberculosis vaccinehigh activity binding peptidemulti-epitope vaccineMycobacterium tuberculosissynthetic peptide

Identifiers

PMID25041568
PMCPMC4233021
OpenAlexW1965497254

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.